Article Correctness Is Author's Responsibility: Updated Contraindications, Dosing for Gaucher Disease Treatment Cerdelga

The article below may contain offensive and/or incorrect content.

Cerdelga is indicated for the long-term treatment of adult patients with Gaucher disease type 1 who are CYP2D6 extensive metabolizers, intermediate metabolizers, or poor metabolizers as detected by an FDA-cleared test.